Mayne Pharma sues Cosette over failed $672M merger
MELBOURNE: ASX-listed Mayne Pharma has taken US drug maker Cosette to court seeking “substantial damages”
MELBOURNE: ASX-listed Mayne Pharma has taken US drug maker Cosette to court seeking “substantial damages”
FEATURED
6 factors support greater market penetration in assisted living
Alzheimer’s diagnosis debate among doctors gives people conflicting results
Redevelopment plans finally announced for 40-unit seniors building
Major 211-home boomer towers planned for heritage hotel site
Intergenerational housing gets green light for major ‘neo-industrial’ neighbourhood
Intergenerational housing to play part in future of city regeneration sites
INNOVATION
